...
首页> 外文期刊>Indian Journal of Medical and Paediatric Oncology >Intra-abdominal desmoplastic small round cell tumor: Presentation of four cases and review of the literature
【24h】

Intra-abdominal desmoplastic small round cell tumor: Presentation of four cases and review of the literature

机译:腹腔内增生性小圆形细胞瘤:4例报道并文献复习

获取原文
           

摘要

Desmoplastic small round cell tumor (DSRCT) of the abdomen is a recently identified aggressive neoplasm. Very few cases have been reported in the literature. Thus, the treatment guidelines are yet to be defined. The role of chemotherapy, radiotherapy and surgery is evolving. We treated four cases of DSRCT involving the abdomen using combination chemotherapy and/or tumor cytoreductive surgery. There were two men and two women. The chemotherapy drugs consisted of cisplatin, adriamycin, etoposide, ifosphamide, vincristine and cyclophsophamide. All patients achieved meaningful partial response to chemotherapy, which maintained for 6–9 months. There were very minimal chemotherapy-related complications. At the time of reporting, the median survival time was 15 months. Thus, DSRCT is an aggressive intra-abdominal tumor with excellent chemoresponsiveness, but relapse is frequent.Keywords: Abdomen, chemotherapy, desmoplastic small round cell tumor, management and prognosis, radiotherapy, surgery
机译:腹部的增生小圆形细胞瘤(DSRCT)是最近发现的侵袭性肿瘤。文献中报道的病例很少。因此,治疗指南尚待确定。化学疗法,放射疗法和外科手术的作用正在发展。我们采用联合化疗和/或肿瘤细胞减灭术治疗了四例涉及腹部的DSRCT。有两个男人和两个女人。化疗药物包括顺铂,阿霉素,依托泊苷,异环磷酰胺,长春新碱和环磷酰胺。所有患者对化疗均取得了有意义的部分反应,维持了6-9个月。与化疗相关的并发症极少。在报告时,中位生存时间为15个月。因此,DSRCT是一种侵袭性的腹腔内肿瘤,具有出色的化学反应性,但复发率很高。关键词:腹部,化学疗法,增生性小圆形细胞肿瘤,治疗和预后,放疗,手术

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号